Evoke Pharma Reports Third Quarter 2018 Results Read more about Evoke Pharma Reports Third Quarter 2018 Results
Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review Read more about Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review
Evoke Pharma Reports Second Quarter 2018 Results and Recent Highlights Read more about Evoke Pharma Reports Second Quarter 2018 Results and Recent Highlights
Evoke Announces FDA Submission of New Drug Application for Gimoti™ Read more about Evoke Announces FDA Submission of New Drug Application for Gimoti™
Evoke Pharma Reports First Quarter 2018 Results and Highlights Read more about Evoke Pharma Reports First Quarter 2018 Results and Highlights
Evoke Granted Gender Specific Patent for Gimoti™ in Mexico Read more about Evoke Granted Gender Specific Patent for Gimoti™ in Mexico
Evoke Granted First Gender Specific Patent for Gimoti™ Read more about Evoke Granted First Gender Specific Patent for Gimoti™
Evoke Announces Agreement with Mallinckrodt to Amend Milestone Payments Read more about Evoke Announces Agreement with Mallinckrodt to Amend Milestone Payments
Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights Read more about Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
Evoke Pharma to Present at the Upcoming Roth and Oppenheimer Investor Conferences Read more about Evoke Pharma to Present at the Upcoming Roth and Oppenheimer Investor Conferences